Chemical Compound

4-O-[2-amino-2,3,4,6-tetradeoxy-6-(ethylamino)-|A-Dglycero-hex-4-enopyranosyl]-2-deoxy-6-O-[3-deoxy-4- C-methyl-3-(methylamino)-|A-L-arabinopyranosyl]-1-Nethyl-D-streptamine (6 inverted exclamation marka-N-ethylnetilmicin); (2R,3R,4R,5R)-2-(((1S,2S,3R,4S,6R)-4-amino-3-(((2S,3R)-3-amino-6-((ethylamino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-6-(ethylamino)-2-hydroxycyclohexyl)oxy)-5-methyl-4-(methylamino)tetrahydro-2H-pyran-3,5-diol

CAS Registry Number 63721-51-7
4-O-[2-amino-2,3,4,6-tetradeoxy-6-(ethylamino)-|A-Dglycero-hex-4-enopyranosyl]-2-deoxy-6-O-[3-deoxy-4- C-methyl-3-(methylamino)-|A-L-arabinopyranosyl]-1-Nethyl-D-streptamine (6 inverted exclamation marka-N-ethylnetilmicin); (2R,3R,4R,5R)-2-(((1S,2S,3R,4S,6R)-4-amino-3-(((2S,3R)-3-amino-6-((ethylamino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-6-(ethylamino)-2-hydroxycyclohexyl)oxy)-5-methyl-4-(methylamino)tetrahydro-2H-pyran-3,5-diol 结构式
Primary record

4-O-[2-amino-2,3,4,6-tetradeoxy-6-(ethylamino)-|A-Dglycero-hex-4-enopyranosyl]-2-deoxy-6-O-[3-deoxy-4- C-methyl-3-(methylamino)-|A-L-arabinopyranosyl]-1-Nethyl-D-streptamine (6 inverted exclamation marka-N-ethylnetilmicin); (2R,3R,4R,5R)-2-(((1S,2S,3R,4S,6R)-4-amino-3-(((2S,3R)-3-amino-6-((ethylamino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-6-(ethylamino)-2-hydroxycyclohexyl)oxy)-5-methyl-4-(methylamino)tetrahydro-2H-pyran-3,5-diol

库存
2,595 克
纯度
99.2 %
CAS
63721-51-7

化合物标识与属性

CAS
63721-51-7
PubChem CID
15344654
SMILES
CCNCC1=CC[C@H]([C@H](O1)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@](CO3)(C)O)NC)O)NCC)N)N
Canonical SMILES
CCNCC1=CC[C@@H](N)[C@@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H](NCC)C[C@@H]2N)O1

名称与同义词

  • 6'-N-Ethylnetilmicin
  • 6 -N-Ethylnetilmicin
  • Netilmicin EP Impurity D
  • 1,6'-Di-N-ethylsisomycin
  • 86VG7L4NNV
  • Netilmicin Sulfate EP Impurity D
  • J546.895G
  • Netilmicin Sulfate EP Impurity D (Free Base)
  • 63721-51-7
  • NETILMICIN SULFATE IMPURITY D [EP IMPURITY]
  • (2R,3R,4R,5R)-2-{[(1S,2S,3R,4S,6R)-4-amino-3-{[(2S,3R)-3-amino-6-[(ethylamino)methyl]-3,4-dihydro-2H-pyran-2-yl]oxy}-6-(ethylamino)-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol
  • 4-O-[[3alpha-Amino-6-[(ethylamino)methyl]-3,4-dihydro-2H-pyran]-2alpha-yl]-6-O-[4-C-methyl-3-(methylamino)-3-deoxy-beta-L-arabinopyranosyl]-N1-ethyl-2-deoxy-D-streptamine
  • 4-O-[2-amino-2,3,4,6-tetradeoxy-6-(ethylamino)-|A-Dglycero-hex-4-enopyranosyl]-2-deoxy-6-O-[3-deoxy-4- C-methyl-3-(methylamino)-|A-L-arabinopyranosyl]-1-Nethyl-D-streptamine (6 inverted exclamation marka-N-ethylnetilmicin); (2R,3R,4R,5R)-2-(((1S,2S,3R,4S,6R)-4-amino-3-(((2S,3R)-3-amino-6-((ethylamino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-6-(ethylamino)-2-hydroxycyclohexyl)oxy)-5-methyl-4-(methylamino)tetrahydro-2H-pyran-3,5-diol
  • 4-O-[2-amino-2,3,4,6-tetradeoxy-6-(ethylamino)-alpha-D-glycero-hex-4-enopyranosyl]-2-deoxy-6-O-[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl]-1-N-ethyl-D-streptamine
  • O-2-Amino-2,3,4,6-tetradeoxy-6-(ethylamino)-alpha-D-glycero-hex-4-enopyranosyl-(1-->4)-O-[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-->6)]-2-deoxy-N1-ethyl-D-streptamine